We provide you with 20 years of free, institutional-grade data for TNGX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TNGX. Explore the full financial landscape of TNGX stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$2,926,762
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Crystal Adam | Sale | -27,000 | $29.34 | $792,245 | 2026-07-02 |
| Crystal Adam | Derivatives Exercise | 27,000 | 2026-07-02 | ||
| Azelby Robert | Grant, award...etc | 5,740 | 2026-06-23 | ||
| Ketchum John B | Grant, award...etc | 4,000 | 2026-06-08 | ||
| Calhoun Lesley Ann | Grant, award...etc | 4,000 | 2026-06-08 | ||
| Rothenberg Mace | Grant, award...etc | 4,000 | 2026-06-08 | ||
| Lee Sung | Grant, award...etc | 570 | 2026-06-08 | ||
| Crystal Adam | Sale | -27,000 | $22.25 | $600,804 | 2026-06-03 |
| Crystal Adam | Derivatives Exercise | 27,000 | 2026-06-03 | ||
| Gall Matthew | Grant, award...etc | 40,000 | 2026-05-05 | ||
| Crystal Adam | Sale | -27,000 | $21.19 | $572,214 | 2026-05-05 |
| Crystal Adam | Derivatives Exercise | 27,000 | 2026-05-05 | ||
| Lee Sung | Grant, award...etc | 12,300 | 2026-05-01 | ||
| Newcomb Jessica | Initial | 2026-04-24 | |||
| Crystal Adam | Sale | -38,460 | $25 | $961,500 | 2026-04-16 |
| Crystal Adam | Derivatives Exercise | 38,460 | 2026-04-16 | ||
| Crystal Adam | Sale | -27,000 | $21.2 | $572,478 | 2026-04-02 |
| Crystal Adam | Derivatives Exercise | 27,000 | 2026-04-02 | ||
| Crystal Adam | Sale | -12,000 | $20.11 | $241,320 | 2026-03-27 |
| Crystal Adam | Derivatives Exercise | 12,000 | 2026-03-27 | ||
| Crystal Adam | Sale | -20,251 | $15 | $303,765 | 2026-03-09 |
| Crystal Adam | Sale | -54,345 | $12.77 | $694,208 | 2026-02-27 |
| Beckman Daniella | Sale | -10,317 | $12.26 | $126,459 | 2026-02-04 |
| Beckman Daniella | Grant, award...etc | 44,330 | 2026-02-04 | ||
| Weber Barbara | Sale | -30,519 | $12.26 | $374,081 | 2026-02-04 |
| Weber Barbara | Grant, award...etc | 37,522 | 2026-02-04 | ||
| Crystal Adam | Sale | -18,452 | $12.26 | $226,172 | 2026-02-04 |
| Crystal Adam | Grant, award...etc | 47,460 | 2026-02-04 | ||
| Peters Malte | Grant, award...etc | 350,000 | 2026-01-12 | ||
| Lee Sung | Grant, award...etc | 10,000 | 2026-01-06 | ||
| Third Rock Ventures IV, L.P. | Sale | -477,401 | $10.15 | $4,846,575 | 2025-10-27 |
| Third Rock Ventures IV, L.P. | Sale | -500,000 | $8.02 | $4,008,500 | 2025-09-29 |
| Third Rock Ventures IV, L.P. | Sale | -363,541 | $7.04 | $2,559,329 | 2025-09-17 |
| Third Rock Ventures IV, L.P. | Sale | -729,365 | $7 | $5,105,555 | 2025-09-09 |
| Third Rock Ventures IV, L.P. | Sale | -302,194 | $7 | $2,115,358 | 2025-08-26 |
| Third Rock Ventures IV, L.P. | Sale | -1,100,000 | $7.01 | $7,712,760 | 2025-08-21 |
| Peters Malte | Grant, award...etc | 6,250 | 2025-06-09 | ||
| Calhoun Lesley Ann | Grant, award...etc | 6,250 | 2025-06-09 | ||
| Ketchum John B | Grant, award...etc | 6,250 | 2025-06-09 | ||
| Rothenberg Mace | Grant, award...etc | 6,250 | 2025-06-09 | ||
| Borisy Alexis | Grant, award...etc | 6,250 | 2025-06-09 | ||
| Barry Douglas | Sale | -5,330 | $2.99 | $15,926 | 2025-02-06 |
| Crystal Adam | Sale | -14,283 | $2.99 | $42,678 | 2025-02-06 |
| Beckman Daniella | Sale | -8,232 | $2.99 | $24,597 | 2025-02-06 |
| Weber Barbara | Sale | -18,791 | $2.99 | $56,148 | 2025-02-06 |
| Barry Douglas | Grant, award...etc | 27,363 | 2025-02-05 | ||
| Beckman Daniella | Grant, award...etc | 26,119 | 2025-02-05 | ||
| Crystal Adam | Grant, award...etc | 53,015 | 2025-02-05 | ||
| Weber Barbara | Grant, award...etc | 105,875 | 2025-02-05 | ||
| Rothenberg Mace | Open Market Purchase | 20,000 | $3.62 | 2024-11-18 | |
| EcoR1 Capital, LLC | Sale | -2,700,000 | $3.28 | $8,844,930 | 2024-11-08 |
| Boxer Capital Management, LLC | Sale | -3,080,000 | $3.14 | $9,671,200 | 2024-11-07 |
| Boxer Capital Management, LLC | Sale | -633,000 | $6.87 | $4,348,710 | 2024-10-28 |
| Boxer Capital Management, LLC | Sale | -875,000 | $7.05 | $6,168,750 | 2024-10-23 |
| Third Rock Ventures IV, L.P. | Sale | -67,400 | $10.53 | $709,756 | 2024-09-17 |
| Third Rock Ventures IV, L.P. | Sale | -75,000 | $11.56 | $867,135 | 2024-09-09 |
| Third Rock Ventures IV, L.P. | Sale | -175,000 | $11.6 | $2,029,703 | 2024-09-04 |
| Third Rock Ventures IV, L.P. | Sale | -25,000 | $11.55 | $288,665 | 2024-08-29 |
| Third Rock Ventures IV, L.P. | Sale | -285,000 | $9.79 | $2,789,723 | 2024-08-20 |
| Third Rock Ventures IV, L.P. | Sale | -235,000 | $9.8 | $2,303,282 | 2024-08-01 |
| Third Rock Ventures IV, L.P. | Sale | -50,000 | $9.84 | $491,950 | 2024-07-30 |
| Third Rock Ventures IV, L.P. | Sale | -300,599 | $9.82 | $2,950,620 | 2024-07-26 |
| Third Rock Ventures IV, L.P. | Sale | -387,740 | $9.78 | $3,792,834 | 2024-07-24 |
| Third Rock Ventures IV, L.P. | Sale | -191,490 | $9.81 | $1,878,479 | 2024-07-22 |
| Borisy Alexis | Grant, award...etc | 6,250 | 2024-06-07 | ||
| Calhoun Lesley Ann | Sale | 5,000 | $7.21 | 2024-06-07 | |
| Calhoun Lesley Ann | Grant, award...etc | 6,250 | 2024-06-07 | ||
| Rothenberg Mace | Grant, award...etc | 6,250 | 2024-06-07 | ||
| Peters Malte | Grant, award...etc | 6,250 | 2024-06-07 | ||
| Ketchum John B | Grant, award...etc | 4,687 | 2024-06-07 | ||
| MVA Investors, LLC | Sale | -210,000 | $7.43 | $1,560,300 | 2024-05-03 |
| Third Rock Ventures IV, L.P. | Sale | -162,500 | $12 | $1,950,000 | 2024-02-21 |
| Weber Barbara | Sale | -9,138 | $12.56 | $114,797 | 2024-02-08 |
| Barry Douglas | Sale | -2,776 | $12.56 | $34,874 | 2024-02-08 |
| Beckman Daniella | Sale | -3,725 | $12.56 | $46,796 | 2024-02-08 |
| Crystal Adam | Sale | -8,371 | $12.56 | $105,162 | 2024-02-08 |
| Crystal Adam | Grant, award...etc | 46,599 | 2024-02-05 |
The information provided in this report about TNGX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Tango Therapeutics Inc(NASDAQ:TNGX) 
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine pho...
Website: https://www.tangotx.com/
Founded: 2017
Founder: Barbara Weber, Alan Ashworth, William Kaelin Jr, Antoni Ribas, José Baselga, and Timothy Lu
CEO: Barbara Weber
Sector: REAL ESTATE & CONSTRUCTION
Industry: BLANK CHECKS
Share this website to your friends